Accuray | ARAY - Umsatzkosten





Umsatzkosten Veränderung Datum
Abbott USD 4.92B 535M 2025-12
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Mesa Laboratories USD 21.92M 1.78M 2024-09
Orthofix International USD 66.63M 6.4M 2025-12
Surmodics USD 9.49M 23.54M 2025-06
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Trinity Biotech USD 7.84M 3.14M 2025-09